Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
Clinical trial NCT01423916 · COMPLETED
Trial details
- NCT number
- NCT01423916
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2012-02-01
- Enrollment
- 218
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.